
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
mRNA-LNP COVID-19 Vaccine Lipids Induce Complement Activation and Production of Proinflammatory Cytokines: Mechanisms, Effects of Complement Inhibitors, and Relevance to Adverse Reactions
Tamás Bakos, Tamás Mészáros, Gergely Tibor Kozma, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3595-3595
Open Access | Times Cited: 10
Tamás Bakos, Tamás Mészáros, Gergely Tibor Kozma, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3595-3595
Open Access | Times Cited: 10
Showing 10 citing articles:
Advances and applications of RNA vaccines in tumor treatment
Ruohan Yang, Jiuwei Cui
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 9
Ruohan Yang, Jiuwei Cui
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 9
Comirnaty-induced cardiopulmonary distress and other symptoms of complement-mediated pseudo-anaphylaxis in a hyperimmune pig model: Causal role of anti-PEG antibodies
Bálint András Barta, Tamás Radovits, Attila Balázs Dobos, et al.
Vaccine X (2024) Vol. 19, pp. 100497-100497
Open Access | Times Cited: 6
Bálint András Barta, Tamás Radovits, Attila Balázs Dobos, et al.
Vaccine X (2024) Vol. 19, pp. 100497-100497
Open Access | Times Cited: 6
Expanded Spectrum and Increased Incidence of Adverse Events Linked to COVID-19 Genetic Vaccines: New Concepts on Prophylactic Immuno-Gene Therapy, Iatrogenic Orphan Disease, and Platform-Inherent Challenges
János Szebeni
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 450-450
Open Access
János Szebeni
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 450-450
Open Access
An Industry Perspective on the Use of Novel Excipients in Lipid Nanoparticles—Nonclinical Considerations
Lorrene A. Buckley, Jessica E. Sutherland, Prachi Borude, et al.
International Journal of Toxicology (2025)
Closed Access
Lorrene A. Buckley, Jessica E. Sutherland, Prachi Borude, et al.
International Journal of Toxicology (2025)
Closed Access
Impact of pre-existing anti-polyethylene glycol (PEG) IgM on biodistribution and humoral response of intramuscularly administered PEGylated mRNA loaded lipid nanoparticle
Satoshi Abe, Haruka Takata, Taro Shimizu, et al.
Journal of Controlled Release (2025), pp. 113821-113821
Closed Access
Satoshi Abe, Haruka Takata, Taro Shimizu, et al.
Journal of Controlled Release (2025), pp. 113821-113821
Closed Access
Myocarditis Associated with COVID-19 Vaccination
Kamila Florek, Mateusz Sokolski
Vaccines (2024) Vol. 12, Iss. 10, pp. 1193-1193
Open Access | Times Cited: 2
Kamila Florek, Mateusz Sokolski
Vaccines (2024) Vol. 12, Iss. 10, pp. 1193-1193
Open Access | Times Cited: 2
In vivo gene editing and in situ generation of chimeric antigen receptor cells for next-generation cancer immunotherapy
Weiyue Zhang, Xin Huang
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Weiyue Zhang, Xin Huang
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Transfusions of Blood Products Derived from Genetic Vaccine Recipients: Safety Concerns and Proposals for Specific Measures
Jun Ueda, Hideyuki Motohashi, Yuriko Hirai, et al.
(2024)
Open Access | Times Cited: 1
Jun Ueda, Hideyuki Motohashi, Yuriko Hirai, et al.
(2024)
Open Access | Times Cited: 1
Immunogenicity risk assessment of empty capsids present in adeno-associated viral vectors using predictive innate immune responses
Nicole L. Jarvi, Kirk Hofman, A. Venkatesh, et al.
Journal of Pharmaceutical Sciences (2024) Vol. 113, Iss. 12, pp. 3457-3469
Closed Access | Times Cited: 1
Nicole L. Jarvi, Kirk Hofman, A. Venkatesh, et al.
Journal of Pharmaceutical Sciences (2024) Vol. 113, Iss. 12, pp. 3457-3469
Closed Access | Times Cited: 1
Transplacental transmission of mRNA injections confirmed: does this evidence by Hanna and colleagues support their proposition as a promising prenatal gene therapy?
Siguna Mueller
(2024)
Open Access
Siguna Mueller
(2024)
Open Access
Comprehensive Toxicology 4e: Complement and Complement-Mediated Toxicity
Shannon M. Twardy, Ashley Frazer‐Abel, Rebecca L. McCullough
Elsevier eBooks (2024)
Closed Access
Shannon M. Twardy, Ashley Frazer‐Abel, Rebecca L. McCullough
Elsevier eBooks (2024)
Closed Access
Exploring the Effects of Incorporating Different Bioactive Phospholipids into Messenger Ribonucleic Acid Lipid Nanoparticle (mRNA LNP) Formulations
Sunny P. Chen, Shuangyu Wang, Suiyang Liao, et al.
ACS Bio & Med Chem Au (2024) Vol. 5, Iss. 1, pp. 154-165
Open Access
Sunny P. Chen, Shuangyu Wang, Suiyang Liao, et al.
ACS Bio & Med Chem Au (2024) Vol. 5, Iss. 1, pp. 154-165
Open Access